CMS has posted revised Medicare gapfill prices, including the 2014 National Limit Amount (NLA), for new molecular pathology codes under the Medicare Clinical Laboratory Fee Schedule (CLFS). CMS will accept reconsideration requests until October 30, 2013. If CMS revises any NLA under the reconsideration process, the revised NLA will be the upper payment limit effective January 1, 2014. Once the reconsideration process is completed, the determination will be final and not be subject to further reconsideration.
This article is presented for informational purposes only and is not intended to constitute legal advice.